T Cell News and Research

Latest T Cell News and Research

New fNIRS -FD instrument can identify affected areas of brain

Monitoring the rehabilitation of patients with neurological damage caused by a stroke, has encouraged Mexican scientists to work in the design and manufacture of a functional infrared spectroscopy (fNIRS -FD ) instrument capable of identifying the affected areas of the brain and the sites that were activated while analyzing the oxygen content in blood flow during therapy.

28 May 2014

Genetically modified swine skin grafts may provide new treatment for burn injuries

A specially-bred strain of miniature swine lacking the molecule responsible for the rapid rejection of pig-to-primate organ transplants may provide a new source of skin grafts to treat seriously burned patients.

28 May 2014

New understanding of toxicity levels of chemotherapy regimens used for early stage breast cancer

Oncologists now have a new understanding of the toxicity levels of specific chemotherapy regimens used for women with early stage breast cancer, according to research from The University of Texas MD Anderson Cancer Center.

28 May 2014

Stem cells in outer blood vessel wall appear to involve in brain reaction following stroke

Two years ago, a new type of stem cell was discovered in the brain that has the capacity to form new cells.

28 May 2014

Commonly used diabetes medications may also have positive effects against cancer cell proliferation

One of the most commonly used medications to control diabetes may also have positive effects against cancer cell proliferation, as show in research done at the Center for Research and Advanced Studies (CINVESTAV) in Mexico.

28 May 2014

Genetic variant linked to sudden cardiac death leads to protein overproduction in heart cells

A genetic variant linked to sudden cardiac death leads to protein overproduction in heart cells, Johns Hopkins scientists report. Unlike many known disease-linked variants, this one lies not in a gene but in so-called noncoding DNA, a growing focus of disease research.

28 May 2014

Findings may help medical researchers identify effective drug targets for triple negative breast cancer

The suppression of two genes reduce breast cancer tumor formation and metastasis by interfering with blood vessel formation and recruitment, report scientists from Houston Methodist and five other institutions in the Proceedings of the National Academy of Sciences (now online).

28 May 2014

Study detects hormone receptor's key role in normal organ development and function

A discovery by UC Irvine endocrinologists about the importance of cell surface receptors for estrogen has the potential to change how researchers view the hormone's role in normal organ development and function.

28 May 2014

Study reveals loss of function of gene RARRES3 in breast cancer cells promotes metastasis to lung

A study published today in EMBO Molecular Medicine reveals that the loss of function of the gene RARRES3 in breast cancer cells promotes metastasis to the lung.

28 May 2014

Study suggests proton therapy may be effective, less toxic treatment option for head and neck cancer

In a small study, researchers from The University of Texas MD Anderson Cancer Center found that 93 percent of head and neck cancer patients treated with multi-field optimization intensity modulated proton therapy (MFO-IMPT) were cancer-free 28 months after treatment.

28 May 2014

Researchers develop new technology that uses HIV virus as tool to fight against hereditary diseases

For the first time researchers have succeeded in altering HIV virus particles so that they can simultaneously, as it were, 'cut and paste' in our genome via biological processes. Developed at the Department of Biomedicine at Aarhus University, the technology makes it possible to repair genomes in a new way.

28 May 2014

Scientists discover group of lymphocytes that protects against intracellular infection

The innate immune system recognizes infectious agents such as viruses and bacteria. A group of lymphocytes known as "innate lymphoid cells" or ILCs plays a central role in the defense of the human body against infective agents.

28 May 2014

Half-life extension technology: an interview with Dermot Pearson, Novozymes Biopharma

A drug's half-life indicates how long a substance will remain active in the body. It is essentially the period of time that it takes for the concentration of the amount of the drug to be reduced by half, and therefore, determines how frequently a drug needs to be administered to maintain its therapeutic effect.

27 May 2014

Scientists find interplay between two specific proteins crucial for flawless repair of crosslink damage

Environmental influences such as ionizing radiation, intense heat or various chemical substances damage the DNA constantly.

27 May 2014

Researchers develop active agents that may improve healing of inflammatory illnesses

It is something like the police force of our body: the immune system. It disables intruding pathogens, it dismantles injured tissue and boosts wound healing. In this form of 'self-defense' inflammatory reactions play a decisive role.

27 May 2014

Inovio announces positive results on DNA-based monoclonal antibody therapy targeting CHIKV

Inovio Pharmaceuticals, Inc. announced today that its novel DNA-based therapeutic monoclonal antibody targeting Chikungunya virus (CHIKV) completely protected mice from a lethal CHIKV challenge.

27 May 2014

EMA recommends marketing authorisation for Octapharma’s human cell line recombinant human FVIII, Nuwiq

Octapharma confirmed today the European Medicines Agency (EMA) has adopted a positive opinion towards human cell line recombinant human FVIII, Nuwiq®, recommending the granting of a marketing authorisation for the medicinal product for treatment and prophylaxis of bleeding (also during and after surgery) in paediatric and adult patients with haemophilia A (congenital FVIII deficiency).

27 May 2014

Research to better understand cell defect that contributes to cancer

A research team from Plymouth University Peninsula Schools of Medicine and Dentistry has received funding from the Biotechnology and Biological Sciences Research Council for research to better understand a cell defect that contributes to diseases such as cancer.

26 May 2014

Dieting may decrease chances for metastases in triple negative breast cancers

Calorie restriction, a kind of dieting in which food intake is decreased by a certain percentage, has been touted as way to help people live longer.

26 May 2014

ILCs play central role in defense of human body against infective agents

26 May 2014

T Cell News and Research

Latest T Cell News and Research

New fNIRS -FD instrument can identify affected areas of brain

Genetically modified swine skin grafts may provide new treatment for burn injuries

New understanding of toxicity levels of chemotherapy regimens used for early stage breast cancer

Stem cells in outer blood vessel wall appear to involve in brain reaction following stroke

Commonly used diabetes medications may also have positive effects against cancer cell proliferation

Genetic variant linked to sudden cardiac death leads to protein overproduction in heart cells

Findings may help medical researchers identify effective drug targets for triple negative breast cancer

Study detects hormone receptor's key role in normal organ development and function

Study reveals loss of function of gene RARRES3 in breast cancer cells promotes metastasis to lung

Study suggests proton therapy may be effective, less toxic treatment option for head and neck cancer

Researchers develop new technology that uses HIV virus as tool to fight against hereditary diseases

Scientists discover group of lymphocytes that protects against intracellular infection

Half-life extension technology: an interview with Dermot Pearson, Novozymes Biopharma

Scientists find interplay between two specific proteins crucial for flawless repair of crosslink damage

Researchers develop active agents that may improve healing of inflammatory illnesses

Inovio announces positive results on DNA-based monoclonal antibody therapy targeting CHIKV

EMA recommends marketing authorisation for Octapharma’s human cell line recombinant human FVIII, Nuwiq

Research to better understand cell defect that contributes to cancer

Dieting may decrease chances for metastases in triple negative breast cancers

ILCs play central role in defense of human body against infective agents

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

T Cell News and Research

Latest T Cell News and Research

Immunology eBook

Advancing brain microphysiological systems (bMPS)

PhD researcher at LifeArc

Unveiling Hidden Potential: Organoids for Disease Modeling in Neuroscience Research

Newsletters you may be interested in